In the Clinic Dyslipidemia

被引：57
作者：
Arvanitis, Marios [1 ]
Lowenstein, Charles J. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 06期
关键词：
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; FOLLOW-UP; RISK; MANAGEMENT; STATINS; SAFETY; WOMEN;
D O I：
10.7326/AITC202306200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking. In addition to lifestyle interventions, lipid-lowering therapy should be considered for persons at moderate to high risk for atherosclerotic cardiovascular disease based on validated risk equations. Statin therapy is the first-line medical treatment for dyslipidemia due to its effectiveness and favorable adverse effect profile, but newer treatments provide additional tools for clinicians to effectively treat dyslipidemia.
引用
收藏
页码：ITC81 / U191
页数：17
相关论文
共 54 条
  • [11] Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017
    Dai, Haijiang
    Abu Much, Arsalan
    Maor, Elad
    Asher, Elad
    Younis, Arwa
    Xu, Yawen
    Lu, Yao
    Liu, Xinyao
    Shu, Jingxian
    Bragazzi, Nicola Luigi
    [J]. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (01) : 50 - 60
  • [12] Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction - Final report of the Lyon Diet Heart Study
    de Lorgeril, M
    Salen, P
    Martin, JL
    Monjaud, I
    Delaye, J
    Mamelle, N
    [J]. CIRCULATION, 1999, 99 (06) : 779 - 785
  • [13] Efficacy and safety of a potent new selective cholesterol absorption inhibitor, Ezetimibe, in patients with primary hypercholesterolemia
    Dujovne, CA
    Ettinger, MP
    McNeer, JF
    Lipka, LJ
    LeBeaut, AP
    Suresh, R
    Yang, B
    Veltri, EP
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10) : 1092 - 1097
  • [14] Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/nejmoa1800389, 10.1056/NEJMoa1800389, 10.1056/NEJMoa1200303]
  • [15] What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice
    Finegold, Judith A.
    Manisty, Charlotte H.
    Goldacre, Ben
    Barron, Anthony J.
    Francis, Darrel P.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (04) : 464 - 474
  • [16] Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
    Fulcher, Jordan
    O'Connell, Rachel
    Voysey, Merryn
    Emberson, Jonathan
    Blackwell, Lisa
    Mihaylova, Borislava
    Simes, John
    Collins, Rory
    Kirby, Adrienne
    Colhoun, Helen
    Braunwald, Eugene
    La Rosa, John
    Pedersen, T. R.
    Tonkin, Andrew
    Davis, Barry
    Sleight, Peter
    Franzosi, Maria Grazia
    Baigent, Colin
    Keech, Anthony
    de Lemos, J.
    Blazing, M.
    Murphy, S.
    Downs, J. R.
    Gotto, A.
    Clearfield, M.
    Holdaas, H.
    Gordon, D.
    Koren, M.
    Dahloef, B.
    Poulter, N.
    Sever, P.
    Knopp, R. H.
    Fellstroem, B.
    Holdaas, H.
    Jardine, A.
    Schmieder, R.
    Zannad, F.
    Goldbourt, U.
    Kaplinsky, E.
    Colhoun, H. M.
    Betteridge, D. J.
    Durrington, P. N.
    Hitman, G. A.
    Fuller, J.
    Neil, A.
    Wanner, C.
    Krane, V.
    Sacks, F.
    Moye, L.
    Pfeffer, M.
    [J]. LANCET, 2015, 385 (9976) : 1397 - 1405
  • [17] Lipoprotein(a): the revenant
    Gencer, Baris
    Kronenberg, Florian
    Stroes, Erik S.
    Mach, Francois
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (20) : 1553 - 1560
  • [18] Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
    Goldberg, Anne C.
    Hopkins, Paul N.
    Toth, Peter P.
    Ballantyne, Christie M.
    Rader, Daniel J.
    Robinson, Jennifer G.
    Daniels, Stephen R.
    Gidding, Samuel S.
    de Ferranti, Sarah D.
    Ito, Matthew K.
    McGowan, Mary P.
    Moriarty, Patrick M.
    Cromwell, William C.
    Ross, Joyce L.
    Ziajka, Paul E.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (03) : S1 - S8
  • [19] CHOLESTEROL AND CORONARY HEART-DISEASE MORTALITY - A 23-YEAR FOLLOW-UP-STUDY OF 9902 MEN IN ISRAEL
    GOLDBOURT, U
    YAARI, S
    [J]. ARTERIOSCLEROSIS, 1990, 10 (04): : 512 - 519
  • [20] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND CARDIOVASCULAR-DISEASE - 4 PROSPECTIVE AMERICAN-STUDIES
    GORDON, DJ
    PROBSTFIELD, JL
    GARRISON, RJ
    NEATON, JD
    CASTELLI, WP
    KNOKE, JD
    JACOBS, DR
    BANGDIWALA, S
    TYROLER, HA
    [J]. CIRCULATION, 1989, 79 (01) : 8 - 15
123456